Lipotoxic diseases

Annual Review of Medicine

Volumn 53, Issue , 2002, Pages 319-336

  Unger, Roger H ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Ceramide; Fatty acid homeostasis; Lipoapoptosis; Lipotoxicity; Metabolic syndrome

Indexed keywords

CERAMIDE; LEPTIN; LEPTIN RECEPTOR; TRIACYLGLYCEROL;

ADIPOSE TISSUE; APOPTOSIS; CARDIOMYOPATHY; DIABETES MELLITUS; GENE MUTATION; HEART MUSCLE CELL; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; LIPID STORAGE; LIPODYSTROPHY; METABOLIC REGULATION; OBESITY; OVERNUTRITION; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ADIPOSE TISSUE; ANIMALS; HOMEOSTASIS; HUMANS; LEPTIN; LIPIDS; METABOLIC SYNDROME X; MYOCARDIUM; OBESITY; RISK FACTORS;

EID: 0036182137     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.53.082901.104057     Document Type: Review

References (73)

1. Positional cloning of the mouse obese gene and its human homologue
2. Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia
3. Regulation of fatty acid homeostasis in cells: Novel role of leptin
4. Diseases of liporegulation: New perspective on obesity and related disorders
5. Leptin physiology: A second look
6. Biochemical studies of the excitable membrane of Paramecium tetraurelia. VII. Sterols and other neutral lipids of cells and cilia
7. The "thrifty genotype" in 1998
8. Adipose tissue as an endocrine organ
9. Adipose tissue as an endocrine organ
10. Leptin plasma cortcentrations are dependent on body fat distribution in obese patients
11. Weight-reducing effects of the plasma protein encoded by the obese gene
12. Effects of the obese gene product on body weight regulation in ob/ob mice
13. Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks
14. Transient effects of long-term leptin supplementation in the prevention of diet-induced obesity in mice
15. Leptin: The tale of an obesity gene
16. Comparing the hypothalamic and extrahypothalamic actions of endogenous hyperleptinemia
17. Direct antidiabetic effect of leptin through triglyceride depletion of tissues
18. OB-Rb gene transfer to leptin-resistant islets reverses diabetogenic phenotype
19. Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase and glucose-stimulated insulin secretion
20. β-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: Impairment in adipocyte-β-cell relationships
21. Fatty acid-induced β-cell apoptosis: A link between obesity and diabetes
22. Lipotoxic heart disease in obese rats: Implications for human obesity
23. What if Minkowski had been ageusic? An alternative angle on diabetes
24. Tissue triglycerides, insulin resistance and insulin production: Implications for hyperinsulinemia of obesity
25. Troglitazone lowers islet fat and restores β-cell function of Zucker diabetic fatty rats
26. Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: Implications for the management of diabetes
27. Role of insulin resistance in human disease (syndrome X): An expanded definition
28. Pathophysiology of insulin resistance in human disease
29. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy
30. Generalized lipodystrophy, congenital and acquired (lipoatrophy)
31. Cardiac findings in generalized lipodystrophy
32. Abnormal splicing of the leptin receptor in diabetic mice
33. Substitution at codon 269 (glutamine?proline) of the leptin receptor (OB-R) cDNA is the only mutation found in the Zucker fatty (falfa) rat
34. Leptin receptor missense mutation in the fatty Zucker rat
35. The role of neuropeptide Y in the antiobesity action of the obese gene product
36. Leptin activation of Stat 3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice
37. Lipotoxicity of β-cells in obesity and in other causes of fatty acid spillover
38. Congenital leptin deficiency is associated with severe early-onset obesity in humans
39. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
40. Lipodystrophy in patients naïve to HIV protease inhibitors
41. Nucleocide reverse transcriptase inhibitor-induced mitochondrial toxicity as an etiology for lipodystrophy
42. Obesity and irregulation of energy balance
43. The role of leptin resistance in the lipid abnormalities of aging
44. Disruption of the relationship between fat content and leptin levels with aging in humans
45. Increased lipogenic capacity of the islets of obese rats. A role in the pathogenesis of NIDDM
46. Enhanced de novo lipogenesis in the leptin-unresponsive pancreatic islets of prediabetic Zucker diabetic fatty rats. Role in the pathogenesis of lipotoxic diabetes
47. Fatty acid transport: Difficult or easy?
48. Membrane transport of long-chain fatty acids: Evidence for a facilitated process
49. A family of fatty acid transporters conserved from mycobacterium to man
50. Tissue specific overexpression of lipoprotein lipase causes tissue specific insulin resistance
51. Leptin, troglitazone and the expression of sterol regulatory element binding proteins in liver and pancreatic islets
52. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodlmers
53. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors
54. The peroxisome proliferator-activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation
55. Role of peroxisome proliferator-activated receptor a in disease of pancreatic β-cells
56. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2
57. A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis
58. Inhibition of fatty acid and cholesterol synthesis of AMP-activated protein kinase
59. The uncoupling protein homologues: UCP-1, UCP-2, UCP-3, StUCP and AtUCP
60. Effect of 5-aminoimidazole4-carboxamide-1-β-D-ribofuranside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats
61. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors
62. Programmed cell death induced by ceramide
63. Human and murine serine-palmitoyl-COA transferase: Cloning, expression and characterization of the key enzyme in sphingolipid synthesis
64. Lipoapoptosis in β-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression
65. Troglitazone prevents mitochondrial alterations, β-cell destruction and diabetes in obese prediabetic rats
66. Protection against lipoapoptosis of β-cells through leptin-dependent maintenance of Bc1-2 expression
67. Novel mouse model of lipotoxic cardiomyopathy
68. Caloric restriction in obese pre-diabetic rats prevents beta-cell depletion, loss of beta-cell GLUT-2 and glucose incompetence
69. Role of nitric oxide in obesity-induced β-cell disease
70. Pancreatic β-cells in obesity: Evidence for induction of functional, morphologic and metabolic abnormalities by increased long-chain fatty acids
71. The cardiomyopathy of obesity
72. Obesity and the heart
73. Obesity cardiomyopathy: Pathophysiology and evolution of the clinical syndrome